AmCad BioMed Corporation cancelled the transaction announced on May 21, 2021

AmCad BioMed Corporation is a Taiwan-based company principally engaged in the research, development and manufacture of computer-aided diagnosis (CAD) medical equipment. The Company’s products include AmCAT-UT Dection, which is a computer-aided detection system of thyroid ultrasound, and AmCAD-UT Diagnosis, which is a computer-aided diagnosis system of thyroid ultrasound. The Company operates in Taiwan, China and Hong Kong markets.